Dr. Reddy's Laboratories (RDY) logo

Dr. Reddy's Laboratories (RDY) stock

Generic medicines , market cap $12B

$14.86
-1.26%

As of Tuesday's close · Live for Pro members at the open

Quality Score
11
Above Average
In its industry
#16of 90
Checks firing
6of 14
Trending up
From 52-week high
-5.2%
under its best in a year

RDY's Quality Score fell 2 points on Tue, Nov 10, to 11. Buying slipped from its highest in 20 days (3 chart checks stopped).

See RDY's 14 chart checksSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Key facts on RDY

Key facts on RDY
The chartAbove every average
Latest filing6-K, Oct 23 Issued a release: "Review Report of Independent Registered Public Accounting Firm To the Shareholders and Board of Directors of Dr. Reddy’s Laboratories Limited"
1 more reason behind RDY's 11, free with an account →1 more reason behind RDY's 11, for Pro members.

RDY catalysts

Coming up

After its last 4 reports it closed -3.0% on average, higher 1 of 4 times.

15 past catalysts since 2020, with sizes and sources, for Pro members.

Why RDY scores 11

Above Averagefor quality, not price, 6 of 14 chart checks firingWhat the Quality Score means

Well above its recent run. RDY scores 11 today, against a median of 6 over its last 20 recorded sessions.

  • +6Chart checks 6 of 14 firing right now, one point each
  • +3Long-term trend above a rising 200-⁠day average, near its 52-⁠week high
  • Size adds
  • Profit addsRead on the last four quarters against the four before, or the last full year where no quarters are filed.

No effect today: Run-up, Growth, Dilution, Volatility, Cash flow, Persistence, and News.

What every line is worth, and the reason behind it, on RDY and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 10:56 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

How RDY ranks in Pharma

RDY is #16 of 90 by Quality Score.

How RDY ranks in Pharma
RankStockQuality Score
16Dr. Reddy's Laboratories (RDY) logoRDYDr. Reddy's Laboratories11

More in Pharma

When does RDY report earnings, and what happens after?

Expected to report Thu Jan 21, before the open (in 72 days).

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

Close after the report, last 3

-5.2%-9.4%-0.1%
May 12Jul 22Oct 23
ReportedGapReaction5
days
Oct 23, 2026Before open+2.2%-0.1%+6.7%
Jul 22, 2026Before open-4.5%-9.4%-6.6%
May 12, 2026Before open-3.0%-5.2%+3.5%

RDY closed higher after 1 of its last 4 reports.

All 4 reports, and RDY's Quality Score going into each

RDY has 6 of 14 chart checks firing

Volume1 of 3 shown
Tight range1 of 3 shown
Buying1 of 3 shown
The other 10 checks on RDY, and all 14 on every stock.Get in free →

RDY RSI today: 73.4, above its 50-day and 200-day averages

Not scored

RSI 73.4, MACD above signal, above both averages. Not scored.

The deep dive on RDY

5 more findings on RDY, each with its source, for Pro members.

Which ETFs hold RDY?

In ETFs: RDY is under 0.1% of VXUS, the most of the 24 funds Breakaway covers, by their holdings as filed for Jul 31, 2026.

About Dr. Reddy's Laboratories

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

27,527 employeesdrreddys.com

Here is what Pro members see.

  • The same page for Pro members, on Microsoft

    Its Quality Score and rank, the line that drives it, and the live price.

  • The full chart

    A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.

  • Every line of the score

    Price action, the company, and signals, each with its points, on RDY and every other stock.

  • CEOs buying their own stock

    Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.

  • Congress trades

    A member's trades, newest first, each with its amount. Sort and filter the whole list.

  • 14 chart checks, read for you

    The ones firing on the stock, each in plain words, its rule a tap away.

  • Earnings, week by week

    Who reports each day, and how each stock took its last four reports.

  • FDA dates, counted down

    Each date in the company's words, its cash against the date, and an optional alert before it.

  • The market map

    Every stock a box, colored by its Quality Score.

  • Themes, ranked live

    Each theme's stocks ranked by Quality Score, live. Here, AI chips.

  • The top 10, every day

    The ten highest Quality Scores at each close, kept day by day, week by week.

  • Optional alerts, your way

    Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.

  • Your watchlist, scored

    Your stocks by Quality Score, today's move, or name.

  • On your phone and your laptop

    The same account and watchlist on both, each laid out for its screen.

  • Prices refresh every 2.5 seconds during market hours.
  • Optional alerts by push, email, or the bell.
  • Add it to your Home Screen and it opens like an app.

Pro members see every line of every stock's score.

  • What would move RDY's score: 5 things
  • 15 more filings explained, a plain line each
  • Real-⁠time prices, no delay
See RDY's 14 chart checks

See it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Straight AnswersStraight Answers

As of Nov 10, 2026: RDY's Quality Score is 11 (Above Average), #16 of 90 in Pharma.

What does RDY's Quality Score say?

RDY scores 11 today, which Breakaway calls Above Average. It is #16 of 90 in Pharma by Quality Score, with 6 of 14 chart checks firing. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is RDY's Quality Score?

RDY scores 11 today, which Breakaway calls Above Average (11 to 14). That is #16 of 90 in Pharma by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind RDY's 11.

When does RDY report earnings?

Expected to report Thu Jan 21, before the open, a date Breakaway expects from the company's usual timing; the company has not confirmed it. RDY closed higher after 1 of its last 4 reports. Past behavior, not a forecast.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

Every US stock, ranked live.

Insider and Congress trades, the chart, and the financials, in one score.

See all 3,168 stocks ranked

See it live, free until Thursday morning. No account. No card. Then keep going with a free account.

The moves after past earnings reports are past behavior, not a forecast.

The price, the score, the chart checks and readings, and the industry rank on this page are delayed at least 15 minutes.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9, 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.